Rankings Pricing

KAKEN PHARMACEUTIAL CO., LTD.【JP:4521】Income statement

Market cap

¥188.4B

P/E ratio

67.5x

Summary Financials Dividends History Segments Ownership Workforce

Income statement Balance sheet Cash flow Other

	2012/03	2013/03	2014/03	2015/03	2016/03	2017/03	2018/03	2019/03	2020/03	2021/03	2022/03	2023/03	2024/03	2025/03
Revenue	87,997	87,054	88,946	93,889	109,730	101,479	98,430	94,165	89,232	74,979	76,034	72,984	72,044	94,035
Cost of revenue	-	-	-	44,760	47,580	44,539	42,405	40,366	38,753	34,073	34,458	33,428	33,505	35,502
Gross profit	-	-	-	49,129	62,149	56,940	56,024	53,799	50,478	40,906	41,575	39,555	38,539	58,532
Gross margin (%)	-	-	-
Operating income	-	-	-	20,631	35,146	30,707	27,496	24,592	26,512	17,788	17,064	7,998	9,513	21,034
Operating expenses	-	-	-	28,504	26,490	26,745	28,530	29,209	23,969	23,118	24,511	31,556	29,025	37,497
Income before tax	14,803	14,250	15,521	20,394	35,365	30,981	27,854	24,972	26,946	18,222	17,542	8,727	9,951	21,279
Provision for income taxes	-	-	-	6,488	14,148	9,075	8,643	7,147	7,222	5,252	4,336	1,377	1,770	5,490
Net income	7,948	8,634	9,395	12,122	21,143	22,017	19,043	17,775	19,370	13,405	9,549	5,440	8,025	13,945
Earnings per share	184.93	206.61	228.27	290.9	510.54	536.7	470.54	445.78	494.89	347.37	251.43	144.8	212.67	365.42
Dividend per share	40	44	48	59	112	150	150	150	150	150	150	150	150	190

Raw aggregated data